Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of SGLT2 Inhibitors on Left Atrium Remodeling in Paroxysmal Atrial Fibrillation
NCT05993897Completed
- Sponsor
- Aswan University
- Start
- Aug 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Atrial fibrillation (AFib) comparing Dapagliflozin with Placebo (2 arms). Primary endpoints: Left atrial remodeling at 6 months, Changes in left atrial strain at 6 months and 1 more. Started Aug 2024; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05993897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05993897.